These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

26 related articles for article (PubMed ID: 10275082)

  • 1. P & T Committee interview: strategies to ensure an effective formulary system.
    Riff L; Hutchinson R
    Hosp Formul; 1988 Nov; 23(11):901-4, 907-8. PubMed ID: 10290754
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The role of the microbiology laboratory in guiding formulary decisions.
    Stratton CW
    Hosp Formul; 1988 Aug; 23(8):654-7. PubMed ID: 10312591
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Formulary decision making: identifying factors that influence P&T committee drug evaluations.
    Segal R; Pathak DS
    Hosp Formul; 1988 Feb; 23(2):174-8. PubMed ID: 10286022
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Application of decision analysis to drug selection for formulary addition.
    Kresel JJ; Hutchings HC; MacKay DN; Weinstein MC; Read JL; Taylor-Halvorsen K; Ashley H
    Hosp Formul; 1987 Jul; 22(7):658-63, 673, 676. PubMed ID: 10282682
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cephalosporin selection: view from a beleaguered P & T committee member.
    Talley JH
    Hosp Formul; 1986 Jan; 21(1):76-8, 83-4. PubMed ID: 10275082
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Formularies: the role of pharmacy-and-therapeutics (P&T) committees.
    Summers KH; Szeinbach SL
    Clin Ther; 1993; 15(2):433-41; discussion 432. PubMed ID: 8519049
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The application of adverse drug reaction data to drug choice decisions made by pharmacy and therapeutics committees. An Australian perspective.
    Weekes LM; Day RO
    Drug Saf; 1998 Mar; 18(3):153-9. PubMed ID: 9530535
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Global formulary review: how do we integrate pharmacogenomic information?
    Poppe LB; Roederer MW
    Ann Pharmacother; 2011 Apr; 45(4):532-8. PubMed ID: 21487085
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Rational drug use (II): Hospital drug and therapeutics committees.
    Manyemba J; Dzuda C; Nyazema NZ
    Cent Afr J Med; 2000 Sep; 46(9):256-9. PubMed ID: 11320773
    [No Abstract]   [Full Text] [Related]  

  • 10. An analytical framework for assessing drug and therapeutics committee structure and work processes in tertiary Brazilian hospitals.
    Lima-Dellamora Eda C; Caetano R; Gustafsson LL; Godman BB; Patterson K; Osorio-de-Castro CG
    Basic Clin Pharmacol Toxicol; 2014 Sep; 115(3):268-76. PubMed ID: 24528496
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Choosing cephalosporins for the formulary.
    Tartaglione TA
    DICP; 1989; 23(7-8 Suppl):S8-12. PubMed ID: 2669381
    [TBL] [Abstract][Full Text] [Related]  

  • 12.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 13.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 14.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 15.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 2.